Medicine guide

Everolimus Synthon 2

As listed in the register: Everolimus Synthon 2,5 mg, tabletten

2,5 mg · tablet

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Everolimus
Made by
Synthon B.V.

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupCancer treatments and immune-system medicinesL01EG02

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made bySynthon B.V.
Active substanceEverolimus
Used inCancer treatments and immune-system medicines
Strength2,5 mg
Formtablet
ClassificationL01EG02 · Cancer treatments and immune-system medicines
Routeoraal gebruik
Dispensing (as stated by the register)Uitsluitend recept
Name in the registerEverolimus Synthon 2,5 mg, tabletten
RVG120850

Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician

Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).

Other strengths and forms

4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.